Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 14, 2026 14:08 ET | Source: Galera Therapeutics

Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement

Combined company to operate as Obsidian Therapeutics, Inc. and to advance Obsidian’s pipeline of novel engineered TIL cell therapies for the treatment of patients with solid tumors.Obsidian’s lead...
April 07, 2026 11:10 ET | Source: BGB Communications, LLC, dba BGB Group

BGB Group Appoints Julie Yoon as Chief Client Officer to Advance Client Engagement Through Breakthrough Thinking

BGB Group appoints Julie Yoon Chief Client Officer to strengthen client engagement & deliver breakthrough thinking across the commercialization lifecycle.
April 07, 2026 10:30 ET | Source: Exousia Pro, Inc.

NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test

Exousia Pro, OTCPK: MAJI, announces the commencement of the first critical phase in bringing its revolutionary cancer screening test to the global market.
March 31, 2026 08:45 ET | Source: Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and...
March 25, 2026 09:04 ET | Source: InnoCare Pharma

InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit

BEIJING, March 25, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual...
March 18, 2026 04:30 ET | Source: Refeyn

Refeyn เปิดตัวเครื่องมือ MyMass เพื่อลดความซับซ้อนในการประเมินคุณภาพตัวอย่างสำหรับชีววิทยาเชิงโครงสร้าง

เมืองออกซ์ฟอร์ด สหราชอาณาจักร, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn ผู้พัฒนาเทคโนโลยีแมสโฟโตเมตรีระดับบุกเบิก ประกาศเปิดตัวเครื่องแมสโฟโตมิเตอร์ MyMass™ (MyMassMP)...
March 18, 2026 04:30 ET | Source: Refeyn

Refeyn lanza el instrumento MyMass para simplificar la evaluación de la calidad de las muestras en biología estructural

OXFORD, Reino Unido, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn, desarrollador de la tecnología pionera de la fotometría de masa, anuncia el lanzamiento del fotómetro de masa MyMass™ (MyMassMP), un...
March 18, 2026 04:30 ET | Source: Refeyn

Refeyn lança instrumento MyMass para simplificar a avaliação da qualidade de amostras de biologia estrutural

OXFORD, Reino Unido, March 18, 2026 (GLOBE NEWSWIRE) -- A Refeyn, desenvolvedora da pioneira tecnologia de fotometria de massa, anuncia o lançamento do fotômetro de massa MyMass™ (MyMassMP), um...
March 18, 2026 04:30 ET | Source: Refeyn

Refeyn, 구조생물학 연구를 위한 샘플 품질 평가 간소화 장비 ‘MyMass’ 출시

영국 옥스퍼드, March 18, 2026 (GLOBE NEWSWIRE) -- 질량 광도(mass photometry) 기술의 선도적 개발사인 Refeyn이 새로운 질량 광도계 MyMass™ mass photometer(MyMassMP)를 출시한다고 발표했다. 이 소형 장비는 “해당 샘플이 추가 분석을 진행하기에 충분히 적합한가?”라는 핵심 연구 질문에...
March 18, 2026 04:30 ET | Source: Refeyn

Refeyn משיקה את המכשיר MyMass לפישוט ההערכה של איכות דגימות עבור ביולוגיה מבנית

אוקספורד, בריטניה, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn, מפתחת טכנולוגיית פוטומטריית מסה פורצת דרך, מכריזה על השקת פוטומטריית המסה MyMass™ (MyMassMP), מכשיר קומפקטי שנועד לספק מענה לשאלת מחקר...